AHA: Fish Oil Plus Statin Reduces Coronary Events - CME Teaching Brief - MedPage Today
By Peggy Peck, Managing Editor, MedPage Today
Reviewed by Zalman S. Agus, MD; Emeritus Professor at the University of Pennsylvania School of Medicine.
November 17, 2005
Also covered by: Forbes, MSNBC, Washington Post
MedPage Today Action Points
* Be aware that this study discusses use of a high dose fish oil supplement that is not available in the United States.
* This study was published as an abstract and presented at a conference either as an oral or poster presentation. These data and conclusions should be considered to be preliminary as they have not yet been reviewed and published in a peer-reviewed publication.
Review
DALLAS, Nov. 17 - Fish oil supplements in high doses combined with statin therapy deliver a one-two punch that reduces major coronary events, particularly for those with established coronary artery disease.
In a Japanese study, patients with a history of coronary disease who took 1,800 mg/day of highly purified eicosapentaenoic acid (EPA) together with statin therapy-either Pravachol (pravastatin) or Zocor (simvastatin)-had a 19% reduction in risk of major coronary events (P=0.048).
Posted by gruwell at November 18, 2005 3:37 PM | TrackBack